Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
A B Nutrition, Inc. is recalling 509 bottles of Piracetam Powder marketed as a dietary supplement because it is an unapproved new drug.
Humco Holding Group is recalling Mercuroclear Antiseptic Anesthetic First Aid products due to potential contamination with Burkholderia gladioli. The recall covers 1,269,846 bottles distributed nationwide.
A B Nutrition, Inc. is recalling 2,980 bottles of Piracetam dietary supplement because it is an unapproved new drug marketed without an approved NDA or ANDA.
A B Nutrition, Inc. is recalling 912 bottles of Aniracetam dietary supplement because it is an unapproved new drug marketed without an approved NDA or ANDA.
K C Pharmaceuticals is recalling 31,704 bottles of Eye Drops advanced relief because the back labels fail to list three active ingredients.
Teva Pharmaceuticals USA is recalling specific lots of Terazosin Hydrochloride Capsules because a foreign capsule was found in one bottle.
Fresenius Kabi USA LLC is recalling 155,900 vials of Calcium Glucosate Injection, USP, 10% due to missing labels. The recall is nationwide.
AstraZeneca is recalling Pulmicort Respules because the budesonide concentration may be slightly above or below the specification range.
AstraZeneca is recalling PULMICORT RESPULES because the budesonide content may be slightly above or below the specification range.
Hospira is recalling 11,412 bags of HEXTEND (Hetastarch) 6% Injection due to a potential leak from the fill tube seal that compromises sterility.
Hospira Inc. is recalling 325,056 bags of 0.9% Sodium Chloride Injection USP, 100 mL, due to a potential lack of assurance of sterility.
Actavis Elizabeth LLC is recalling 9,264 bottles of amphetamine extended-release capsules because the product failed to meet dissolution specifications.
Bristol Myers Squibb is recalling specific Abilify 30 mg tablets because rejected material was inadvertently shipped. The affected product was distributed in LA, TN, and CA.
Aaron Industries is recalling Rite Aid Maximum Strength Tussin Cough & Cold Mucus Relief CF due to the presence of a white precipitate.
Aaron Industries is recalling 6,108 bottles of Walgreens Wal-Tussin CF Max because a white substance, confirmed as the active ingredient guaifenesin, was observed in some bottles.
Glenmark Generics Inc. is recalling Montelukast Sodium Tablets, 10 mg, due to trace levels of chemical contaminants causing off-odors.
West-ward Pharmaceutical Corp. is recalling VersaPharm Ethambutol Tablets USP 400 mg because the tablet cores may be discolored.
Aaron Industries Inc is recalling Select Brand Cough Control CF Max bottles due to the presence of a white precipitate, identified as the active ingredient guaifenesin.
Aaron Industries is recalling Wal-Mart Equate Tussin CF bottles containing a white precipitate. The substance is confirmed as guaifenesin, an active ingredient.
Hospira is recalling 63,900 vials of Furosemide Injection USP because a loose crimp on the vial cap may compromise sterility.
Pacira Pharmaceuticals is recalling 324 vials of EXPAREL (bupivacaine liposome injectable suspension) because the product is subpotent.
Hospira Inc. is recalling 56,854 units of 0.9% Sodium Chloride Irrigation, USP, 3000 mL, due to a potential leak from the administration port that compromises sterility.
West-ward Pharmaceutical Corp. is recalling Isoniazid Tablets 300 mg due to failed dissolution specifications and a 36-month stability timepoint issue.
Amedra Pharmaceuticals is recalling 12,948 bottles of Dextroamphetamine Sulfate Extended Release Capsules because they may not meet dissolution specifications over their shelf life.
Dr. Reddy's is recalling specific lots of Citalopram tablets because patients reported a strong garlic or chemical smell.